Survey Shows Low Awareness and Purchase Intent on HTG Molecular Diagnostics (HTGM); Leerink Partners Cuts Price Target to $10

Go back to Survey Shows Low Awareness and Purchase Intent on HTG Molecular Diagnostics (HTGM); Leerink Partners Cuts Price Target to $10

HTG Molecular Diagnostics (HTGM) Tops Q3 EPS by 9c

November 12, 2015 4:42 PM EST

HTG Molecular Diagnostics (NASDAQ: HTGM) reported Q3 EPS of ($0.76), $0.09 better than the analyst estimate of ($0.85). Revenue for the quarter came in at $1 million versus the consensus estimate of $1.07 million.

For earnings history and earnings-related data on HTG Molecular Diagnostics (HTGM) click here.

... More

Trading Radar for 11/12: Cisco (CSCO), Viacom (VIAB), Himax (HIMX), Planet Fitness (PLNT), Fossil (FOSL) Report

November 11, 2015 3:47 PM EST

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EST

Initial Claims - Street sees 269kContinuing Claims - Street sees 2.155M

Earnings:

500.com Ltd. (NYSE: WBAI) - consensus loss $0.07
AdCare Health Systems (NYSE: ADK) - no Street consensus
Advance Auto Parts (NYSE: AAP) - consensus EPS $2.09
Air Industries Group (NYSE: AIRI) - consensus EPS $0.09
Aldeyra Therapeutics (Nasdaq:... More